Le Lézard

Body Fluid Analysis Market worth $3.65 billion by 2031 | MarketsandMarketstm

According to MarketsandMarketstm, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9%. Browse ...

Body Fluid Analysis Market worth $3.65 billion by 2031 | MarketsandMarkets™

According to MarketsandMarkets™, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to ...
Technology Networks

Blood Secrets: Advances in Plasma Proteomics for Early Disease Detection

This article explores how new technologies in plasma proteomics enable the simultaneous analysis of thousands of proteins, ...

Genomic Testing Cooperative Highlights Expanded Role of CSF-Based Molecular Profiling Following NCCN Update

Genomic Testing Cooperative (GTC) today highlighted its Liquid Trace® cerebrospinal fluid (CSF)-based molecular profiling ...
C&EN

Self-driving labs are changing how chemists work

A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...
The Manila Times

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), announced today that it has signed a national agreement with Elevance Health, ...

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath Inc., the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ...